EMBL-EBI | Chemical Biology | ChEBI

Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search

CHEBI:64357 - rituximab

ChEBI IDCHEBI:64357
ChEBI Namerituximab
Stars
DefinitionFab domain of rituximab binds to the CD20 antigen on B 645 lymphocytes, and the Fc domain recruits immune effector functions to mediate B-cell lysis in vitro
Last Modified10 April 2012
ChEBI Ontology
Outgoing Relation(s)
rituximab (CHEBI:64357) has role anti-anaemic agent (CHEBI:75835)
rituximab (CHEBI:64357) has role anti-inflammatory agent (CHEBI:67079)
rituximab (CHEBI:64357) has role antifibrotic agent (CHEBI:233423)
rituximab (CHEBI:64357) has role antineoplastic agent (CHEBI:35610)
rituximab (CHEBI:64357) has role antipsychotic agent (CHEBI:35476)
rituximab (CHEBI:64357) has role antirheumatic drug (CHEBI:35842)
rituximab (CHEBI:64357) has role antithyroid drug (CHEBI:50671)
rituximab (CHEBI:64357) has role antiviral agent (CHEBI:22587)
rituximab (CHEBI:64357) has role cardiovascular drug (CHEBI:35554)
rituximab (CHEBI:64357) has role gout suppressant (CHEBI:35845)
rituximab (CHEBI:64357) has role hypoglycemic agent (CHEBI:35526)
rituximab (CHEBI:64357) has role immunosuppressive agent (CHEBI:35705)
rituximab (CHEBI:64357) has role nephroprotective agent (CHEBI:76595)
rituximab (CHEBI:64357) has role ophthalmology drug (CHEBI:66981)
rituximab (CHEBI:64357) has role renoprotective agent (CHEBI:231911)
rituximab (CHEBI:64357) is a organic molecular entity (CHEBI:50860)
rituximab (CHEBI:64357) is a unclassifieds (CHEBI:27189)
INN  Source
zuberitamabWHO MedNet
Synonyms  Source
ABP-798ChEMBL
ABP798ChEMBL
Bi 695500ChEMBL
Bi-695500ChEMBL
BI695500ChEMBL
BlitzimaChEMBL
Brand Names  Source
MabtheraChEMBL
Mabthera rituxanChEMBL
RituxanChEMBL
Rituximab component of rituxan hycelaChEMBL
Rituzena (previously tuxella)ChEMBL
RixathonChEMBL
Citations